TGFB1 and metabolic dysfunction-associated steatohepatitis: In the context of NAFLD-NASH, this is of particular interest since TGFB1 drives the development of fibrosis, and we have demonstrated that although fibrosis was not quantitatively affected in this model, remodeling of collagen fibers did take place in semaglutide-treated mice.